The Sturge-Weber Foundation (The SWF) global mission is to improve the quality of life and care for people with Sturge-Weber syndrome and associated Port-Wine Birthmark conditions through tenacious collaboration with clinical partners and pioneers, education, advocacy, research and friendly support. Learn more and get involved.
Becoming a member of the Sturge-Weber Foundation is absolutely free. It provides us the opportunity to keep you informed on updated medical information, special events or just to say hello and see how you are doing!
What's New In Research
Sturge Weber Twitter
Matthew Shirley, PhD, Senior Expert Data Scientist, Novartis Institutes of Biomedical Research, Cambridge, MA will transition into the Chief Scientific Officer role for the SWF.
Thursday, April 15th, Qlaris announced its first patient enrollment in a 1/2 clinical program of QLS-101. QLS-101, is an investigational therapy designed to lower intraocular pressure (IOP) by reducing episcleral venous pressure (EVP) in individuals with glaucoma.